Ashok Tehim

713 total citations
27 papers, 587 citations indexed

About

Ashok Tehim is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Ashok Tehim has authored 27 papers receiving a total of 587 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Organic Chemistry, 12 papers in Molecular Biology and 8 papers in Pharmacology. Recurrent topics in Ashok Tehim's work include Synthesis of Organic Compounds (8 papers), Receptor Mechanisms and Signaling (5 papers) and Nicotinic Acetylcholine Receptors Study (5 papers). Ashok Tehim is often cited by papers focused on Synthesis of Organic Compounds (8 papers), Receptor Mechanisms and Signaling (5 papers) and Nicotinic Acetylcholine Receptors Study (5 papers). Ashok Tehim collaborates with scholars based in United States, India and Canada. Ashok Tehim's co-authors include Stephen Hanessian, Patrick M. Callahan, Gregory M. Rose, Allen T. Hopper, Michael De Vivo, Ping Chen, Alvin V. Terry, Donald T. Witiak, Michael H. Ossipov and Geihan Rizkalla and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and The Journal of Organic Chemistry.

In The Last Decade

Ashok Tehim

26 papers receiving 551 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ashok Tehim United States 11 332 172 170 156 102 27 587
Kevin J. Hodgetts United States 16 275 0.8× 353 2.1× 134 0.8× 65 0.4× 95 0.9× 32 769
Hirokazu Annoura Japan 15 254 0.8× 298 1.7× 208 1.2× 68 0.4× 115 1.1× 28 683
Sui‐Po Zhang United States 19 537 1.6× 102 0.6× 416 2.4× 119 0.8× 177 1.7× 45 976
Monica Norcini Italy 16 220 0.7× 141 0.8× 210 1.2× 72 0.5× 166 1.6× 23 568
Teresa Domènech Spain 17 434 1.3× 282 1.6× 178 1.0× 125 0.8× 197 1.9× 29 915
Camille‐Georges Wermuth France 15 352 1.1× 334 1.9× 330 1.9× 84 0.5× 106 1.0× 55 852
Kenneth L. Hauser United States 7 239 0.7× 149 0.9× 212 1.2× 97 0.6× 54 0.5× 9 594
Irfan Baig United States 11 303 0.9× 124 0.7× 126 0.7× 204 1.3× 210 2.1× 14 607
Harshad K. Rami United Kingdom 16 265 0.8× 154 0.9× 116 0.7× 94 0.6× 302 3.0× 24 854
Yoshinori Sekiguchi Japan 17 343 1.0× 277 1.6× 111 0.7× 66 0.4× 43 0.4× 41 732

Countries citing papers authored by Ashok Tehim

Since Specialization
Citations

This map shows the geographic impact of Ashok Tehim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashok Tehim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashok Tehim more than expected).

Fields of papers citing papers by Ashok Tehim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashok Tehim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashok Tehim. The network helps show where Ashok Tehim may publish in the future.

Co-authorship network of co-authors of Ashok Tehim

This figure shows the co-authorship network connecting the top 25 collaborators of Ashok Tehim. A scholar is included among the top collaborators of Ashok Tehim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashok Tehim. Ashok Tehim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hay, Justin L., et al.. (2016). No evidence of potentiation of buprenorphine by milnacipran in healthy subjects using a nociceptive test battery. European Journal of Pain. 21(3). 494–506. 6 indexed citations
2.
Callahan, Patrick M., Alvin V. Terry, & Ashok Tehim. (2014). Effects of the nicotinic α7 receptor partial agonist GTS-21 on NMDA-glutamatergic receptor related deficits in sensorimotor gating and recognition memory in rats. Psychopharmacology. 231(18). 3695–3706. 36 indexed citations
3.
Wallace, Tanya L., Patrick M. Callahan, Ashok Tehim, et al.. (2010). RG3487, a Novel Nicotinic α7 Receptor Partial Agonist, Improves Cognition and Sensorimotor Gating in Rodents. Journal of Pharmacology and Experimental Therapeutics. 336(1). 242–253. 100 indexed citations
4.
Spiller, Krista J., Zheng‐Xiong Xi, Xia Li, et al.. (2009). Varenicline attenuates nicotine-enhanced brain-stimulation reward by activation of α4β2 nicotinic receptors in rats. Neuropharmacology. 57(1). 60–66. 51 indexed citations
5.
6.
Rose, Gregory M., Allen T. Hopper, Michael De Vivo, & Ashok Tehim. (2005). Phosphodiesterase Inhibitors for Cognitive Enhancement. Current Pharmaceutical Design. 11(26). 3329–3334. 99 indexed citations
7.
Jarvie, Keith R., et al.. (2005). N-[(3S)-1-Benzylpyrrolidin-3-yl]-(2-thienyl)benzamides: Human dopamine D4 ligands with high affinity for the 5-HT2A receptor. Bioorganic & Medicinal Chemistry Letters. 15(23). 5253–5256. 10 indexed citations
8.
Jarvie, Keith R., et al.. (2004). N-(1-Benzylpyrrolidin-3-yl)arylbenzamides as potent and selective human dopamine D4 antagonists. Bioorganic & Medicinal Chemistry Letters. 14(19). 4847–4850. 5 indexed citations
9.
Demchyshyn, Lidia, et al.. (2003). 3-(2-Pyrrolidin-1-ylethyl)-5-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives as high affinity human 5-HT1B/1D ligands. Bioorganic & Medicinal Chemistry Letters. 14(3). 727–729. 1 indexed citations
10.
Isaac, Methvin, Louise Edwards, Julie M. Wilson, et al.. (2003). Design, synthesis and biological activity of novel dimethyl-{2-[6-substituted-indol-1-yl]-ethyl}-amine as potent, selective, and orally-Bioavailable 5-HT 1D agonists. Bioorganic & Medicinal Chemistry Letters. 13(24). 4409–4413. 5 indexed citations
11.
Demchyshyn, Lidia, et al.. (2003). (R)-3-(N-Methylpyrrolidin-2-ylmethyl)-5-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives as high affinity h5-HT1B/1D ligands. Bioorganic & Medicinal Chemistry Letters. 13(20). 3419–3421. 4 indexed citations
12.
Isaac, Methvin, Angela Naismith, Julie M. Wilson, et al.. (2002). 1-(Bicyclopiperazinyl)ethylindoles and 1-(homopiperazinyl)ethyl-indoles as highly selective and potent 5-HT7 receptor ligands. Bioorganic & Medicinal Chemistry Letters. 12(17). 2451–2454. 9 indexed citations
13.
Owolabi, Joshua B., Geihan Rizkalla, Ashok Tehim, et al.. (1999). Characterization of Antiallodynic Actions of ALE-0540, a Novel Nerve Growth Factor Receptor Antagonist, in the Rat. Journal of Pharmacology and Experimental Therapeutics. 289(3). 1271–1276. 86 indexed citations
14.
Hanessian, Stephen, et al.. (1996). A remarkably facile and stereochemically controlled fragmentation reaction in the hygrolide group of macrolide antibiotics. Tetrahedron Letters. 37(50). 9001–9004. 16 indexed citations
15.
Hanessian, Stephen, Ashok Tehim, & Ping Chen. (1993). Total synthesis of (-)-tetrahydrolipstatin. The Journal of Organic Chemistry. 58(27). 7768–7781. 67 indexed citations
16.
17.
AHLUWALIA, V. K., et al.. (1987). ChemInform Abstract: Synthesis and Antimicrobial Activity of Substituted 3,4‐Dihydro‐2H‐1‐benzopyrans.. ChemInform. 18(43). 8 indexed citations
18.
AHLUWALIA, V. K. & Ashok Tehim. (1985). ChemInform Abstract: A NEW ROUTE TOWARDS THE SYNTHESIS OF DIHYDROPYRANOXANTHONES. Chemischer Informationsdienst. 16(23). 1 indexed citations
19.
Tehim, Ashok, et al.. (1984). A New Route towards the Synthesis of Dihydropyranoxanthones. Heterocycles. 22(12). 2703–2703. 2 indexed citations
20.
Tehim, Ashok, et al.. (1983). Synthesis of carboxy-2,2-dimethylchromans and chromenes. Monatshefte für Chemie - Chemical Monthly. 114(12). 1381–1390.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kevin J. Hodgetts Breakdown of academic impact, for papers by Hirokazu Annoura Breakdown of academic impact, for papers by Sui‐Po Zhang Breakdown of academic impact, for papers by Monica Norcini Breakdown of academic impact, for papers by Teresa Domènech Breakdown of academic impact, for papers by Camille‐Georges Wermuth Breakdown of academic impact, for papers by Kenneth L. Hauser Breakdown of academic impact, for papers by Irfan Baig Breakdown of academic impact, for papers by Harshad K. Rami Breakdown of academic impact, for papers by Yoshinori Sekiguchi
Rankless by CCL
2026